MENU

BLFS Stock 6 Insiders at BioLife Solutions (BLFS, $25.05) sold 2,218 shares last week for $56.4K

A.I.dvisor
at Tickeron.com
Loading...
BLFS - BioLife Solutions
Tickeron

Loading...

Price: $25.05
Daily change: +$0.13 (+0.52%)
Daily volume: 354.5K
Capitalization: $1.2B
Industry: Pharmaceuticals: Other

In the week ending September 1, 2025 six insiders at BioLife Solutions (BLFS, $25.05) sold a total of 2,218 shares for proceeds of $56.4K. Year-to-date, a total of six BioLife Solutions officers have sold 15,648 shares worth $386.9K. Here are the insiders making moves:

WICHTERMAN TROY, Chief Financial Officer – sold 590 shares of BLFS between August 25 - September 01, 2025. Total $15K.

MATHEW ABY J., EVP & Chief Scientific Officer – sold 531 shares of BLFS between August 25 - September 01, 2025. Total $13.5K.

FOSTER KAREN A., Chief Quality and Operations – sold 413 shares of BLFS between August 25 - September 01, 2025. Total $10.5K.

BERARD TODD, Chief Marketing Officer – sold 354 shares of BLFS between August 25 - September 01, 2025. Total $9K.

AEBERSOLD SARAH, Chief Human Resources Officer – sold 219 shares of BLFS between August 25 - September 01, 2025. Total $5.6K.

WERNER SEAN, Chief Technology Officer – sold 111 shares of BLFS between August 25 - September 01, 2025. Total $2.8K.

BLFS in -2.85% downward trend, declining for three consecutive days on August 28, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BLFS declined for three days, in of 288 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for BLFS moved out of overbought territory on August 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where BLFS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

BLFS broke above its upper Bollinger Band on August 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 29, 2025. You may want to consider a long position or call options on BLFS as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BLFS just turned positive on August 08, 2025. Looking at past instances where BLFS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

BLFS moved above its 50-day moving average on August 08, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BLFS crossed bullishly above the 50-day moving average on August 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BLFS advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 210 cases where BLFS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BLFS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLFS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.457) is normal, around the industry mean (10.933). P/E Ratio (0.000) is within average values for comparable stocks, (58.441). BLFS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.824). BLFS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (12.579) is also within normal values, averaging (38.282).

View a ticker or compare two or three
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BLFS showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary and generic bio preservation media products for cells, tissues and organs

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3303 Monte Villa Parkway
Phone
+1 425 402-1400
Employees
414
Web
https://www.biolifesolutions.com